A study of medication use within insured patients with chronic diseases
DOI:
https://doi.org/10.24941/ijcr.31678.08.2018Keywords:
Full Compliance, Morisky Medication Adherence, Chronic Diseases. Yemen.Abstract
Who to site thise artical:
-
-
Alyahawi, A., & Al-wesabi, M. (2018). A study of medication use within insured patients with chronic diseases. International Journal of Current Research, 10(08), 72273-72281. https://doi.org/10.24941/ijcr.31678.08.2018
-
Background: A key component in the management of a patient with chronic health problem is the assessment of its adherence with therapeutic regimen. Low levels of patient adherence with disease plans compromise the effectiveness of the therapies and have been associated with an increased risk of adverse health outcomes. Improving medication adherence with chronic diseases has been historically challenging due to its complex and patient-specific nature.
Methods: Prospective evaluation of medications for187 insured patients with chronic diseases were included in the present study at the time of their visit to outpatient clinics at 48 model hospital (from October to December, 2017). The Morisky Medication Adherence 4-item Scale (Morisky et al., 1986) (MMAS-4) was used to measure patients self-reported adherence to their medications. The instrument has been widely used and it has been demonstrated to be accurate to assess medication adherence in patients with chronic diseases.
Results: Among 187 of patients, 51.9% have more than five types of drugs and 86.1% of them were high adherence to use the drugs. Up to half of patients (52.9%) were non-educated, 88.8% of patients take of medication according to prescription, 86.1% of total patients were full compliance and 89.9% of these patients recognized their medication.
Conclusion: The results of this study provided evidence about the high prevalence of adherence to prescribed medications in insured individuals affected by chronic diseases. This suggested the positive role of insurance coverage in increasing the compliance rate among patients with chronic diseases at health care organizations.
-
References
• Alhewiti, A. (2014). Adherence to Long-Term Therapies and Beliefs about Medications. International Journal of Family Medicine, 2014, Article 479596. https://doi.org/10.1155/2014/479596
• Balbay, O., Annakkaya, A. N., Arbak, P., Bilgin, C., & Erbas, M. (2005). Which patients are able to adhere to tuberculosis treatment? A study in a rural area in the northwest part of Turkey. Japanese Journal of Infectious Diseases, 58(3), 152-158
• Bjerrum, L., Rosholm, J. U., & Hallas, J. (1997). Methods for Estimating the Occurrence of Polypharmacy by Means of a Prescription Database. European Journal of Clinical Pharmacology, 53(1), 7-11. https://doi.org/10.1007/s002280050329
• Buck, D., Jacoby, A., Baker, G. A., & Chadwick, D. W. (1997). Factors influencing compliance with antiepileptic drug regimes. Seizure, 6(2), 87-93. https://doi.org/10.1016/s1059-1311(97)80060-x
• Charlesworth, C. J., Smit, E., Lee, D. S. H., Alramadhan, F., & Odden, M. C. (2015). Polypharmacy among adults aged 65 years and older in the United States: 1988–2010. The Journals of Gerontology: Series A, 70(8), 989-995. https://doi.org/10.1093/gerona/glv013
• Cruzeta, A. P. S., Dourado, A. C. L., Monteiro, M. T. M., Martins, R. O., Calegario, T. A., & Galato, D. (2017). Fatores associados à compreensão da prescrição médica no Sistema Único de Saúde de um município do Sul do Brasil. Ciência & Saúde Coletiva, 18(12), 3731-3737. https://doi.org/10.1590/S1413-81232013001200028
• Goh, B. Q., Tay, A. H. P., Khoo, R. S. Y., Goh, B. K., Lo, P. L., & Lim, C. J. F. (2014). Effectiveness of Medication Review in Improving Medication Knowledge and Adherence in Primary Care Patients. Proceedings of Singapore Healthcare, 23(2), 113-120. https://doi.org/10.1177/201010581402300205
• Gu, Q., Dillon, C. F., & Burt, V. L. (2010). Prescription Drug Use Continues to Increase: U.S. Prescription Drug Data for 2007–2008. NCHS Data Brief, no 42. National Center for Health Statistics.
• Helling, D. K., Lemke, J. H., Semla, T. P., Wallace, R. B., Lipson, D. P., & Cornoni-Huntley, J. (1987). Medication use characteristics in the elderly: The Iowa 65+ Rural Health Study. Journal of the American Geriatrics Society, 35(1), 4-12. https://doi.org/10.1111/j.1532-5415.1987.tb01314.x
• Iskedjian, M., Einarson, T. R., MacKeigan, L. D., Shear, N., Addis, A., Mittmann, N., & Ilersich, A. L. (2002). Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: evidence from a meta-analysis. Clinical Therapeutics, 24(2), 302-316. https://doi.org/10.1016/S0149-2918(02)85031-2
• Jansa, M., Hernandez, C., Vidal, M., Nuñez, M., Carral, M., Viaplana, J., Clinton, J., & Esmatjes, E. (2010). Multidimensional analysis of treatment adherence in patients with multiple chronic conditions: A cross-sectional study in a tertiary hospital. Patient Education and Counseling, 81(2), 161-168. https://doi.org/10.1016/j.pec.2010.02.001
• Kantor, E. D., Rehm, C. D., Haas, J. S., Chan, A. T., & Giovannucci, E. L. (2015). Trends in prescription drug use among adults in the United States from 1999-2012. JAMA, 314(17), 1818-1830. https://doi.org/10.1001/jama.2015.13766
• Maciejewski, M. L., Bryson, C. L., Perkins, M., Blough, D. K., Cunningham, F. E., Fortney, J. C., & Choudhry, N. K. (2010). Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. The American Journal of Managed Care, 16(1), 20-34.
• Mendes, L. V., Campos, M. R., Chaves, G. C., Silva, R. M., Freitas, P. S., Costa, K. S., & Luiza, V. L. (2014). Disponibilidade de medicamentos nas unidades básicas de saúde e fatores relacionados: uma abordagem transversal. Saúde em Debate, 38(spe), 109-123. https://doi.org/10.5935/0103-1104.2014S009
• Mengue, S. S., Bertoldi, A. D., Boing, A. C., Tavares, N. U. L., da Silva Dal Pizzol, T., Oliveira, M. A., & Arrais, P. S. D. (2016). Pesquisa Nacional sobre Acesso, Utilização e Promoção do Uso Racional de Medicamentos (PNAUM): métodos do inquérito domiciliar. Revista de Saúde Pública, 50(supl 2), 4s. https://doi.org/10.1590/S1518-8787.2016050006155
• Morisky, D. E., Green, L. W., & Levine, D. M. (1986). Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care, 24(1), 67-74. https://doi.org/10.1097/00005650-198601000-00007
• Mujtaba, S. F., Masood, T., & Saad, M. (2010). Reasons of Medical Noncompliance in Heart Failure Patients. Pakistan Heart Journal, 43(3-4), 33-38.
• Napolitano, F., Napolitano, P., & Angelillo, I. F. (2016). Medication adherence among patients with chronic conditions in Italy. European Journal of Public Health, 26(1), 48-52. https://doi.org/10.1093/eurpub/ckv147
• Nichols-English, G., & Poirier, S. (2000). Optimizing adherence to pharmaceutical care plans. Journal of the American Pharmaceutical Association, 40(4), 475-485. https://doi.org/10.1016/S1086-5802(16)31097-9
• Nobili, A., Marengoni, A., Tettamanti, M., Salerno, F., Pasina, L., Franchi, C., Iorio, A., Marcucci, M., Corrao, S., Licata, G., & Mannucci, P. M. (2011). Association between clusters of diseases and polypharmacy in hospitalized elderly patients: Results from the REPOSI study. European Journal of Internal Medicine, 22(6), 597-602. https://doi.org/10.1016/j.ejim.2011.08.028
• O'Dwyer, M., Peklar, J., McCallion, P., McCarron, M., & Henman, M. C. (2016). Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study. BMJ Open, 6(4), e010505. https://doi.org/10.1136/bmjopen-2015-010505
• Osborn, C. Y., Mayberry, L. S., Wagner, J. A., Nelson, L. A., & Rothman, R. L. (2014). Stressors may compromise medication adherence among adults with diabetes and low socioeconomic status. Western Journal of Nursing Research, 36(9), 1091-1110. https://doi.org/10.1177/0193945914524278
• Oung, A. B., Kosirog, E., Chavez, B., Brunner, J., & Saseen, J. J. (2017). Evaluation of medication adherence in chronic disease at a federally qualified health center. Therapeutic Advances in Chronic Disease, 8(8-9), 113-120. https://doi.org/10.1177/2040622317714972
• Sabaté, E. (2003). Adherence to long-term therapies: evidence for action. World Health Organization.
• Shalansky, S. J., & Levy, A. R. (2002). Effect of number of medications on cardiovascular therapy adherence. The Annals of Pharmacotherapy, 36(10), 1532-1538. https://doi.org/10.1177/106002800203601001
• Silveira, E. A., Dalastra, L., & Pagotto, V. (2014). Polifarmácia, doenças crônicas e marcadores nutricionais em idosos. Revista Brasileira de Epidemiologia, 17(4), 818-829. https://doi.org/10.1590/1809-4503201400040002
• Tang, F., Zhu, G., Jiao, Z., Ma, C., & Wang, B. (2013). Self-reported adherence in patients with epilepsy who missed their medications and reasons for nonadherence in China. Epilepsy & Behavior, 27(1), 85-89. https://doi.org/10.1016/j.yebeh.2012.12.020
• Tavares, N. U. L., Bertoldi, A. D., Thumé, E., Facchini, L. A., França, G. V. A., & Mengue, S. S. (2013). Fatores associados à baixa adesão ao tratamento medicamentoso em idosos. Revista de Saúde Pública, 47(6), 1092-1101. https://doi.org/10.1590/S0034-8910.2013047004634
• Volpe, M., Chin, D., & Paneni, F. (2010). The challenge of polypharmacy in cardiovascular medicine. Fundamental & Clinical Pharmacology, 24(1), 9-17. https://doi.org/10.1111/j.1472-8206.2009.00787.x
• Wang, Y., Lee, J., Toh, M. P., Tang, W. E., & Ko, Y. (2012). Validity and reliability of a self-reported measure of medication adherence in patients with Type 2 diabetes mellitus in Singapore. Diabetic Medicine, 29(9), e338-e344. https://doi.org/10.1111/j.1464-5491.2012.03714.x
• Wild, M. R., Engleman, H. M., Douglas, N. J., & Espie, C. A. (2004). Can psychological factors help us to determine adherence to CPAP? A prospective study. European Respiratory Journal, 24(3), 461-465. https://doi.org/10.1183/09031936.04.00114503
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 د. علي اليحوي، د. منير مصلح الوصابي (المؤلف)

This work is licensed under a Creative Commons Attribution 4.0 International License.